
Newly Diagnosed MOGAD Patients Show High Recovery Rates in Population-Based Study
Kaiser Permanente reported findings from a study of 69 children and adults diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). More than 80% recovered fully, while just under 12% experienced another attack during a median follow-up of approximately 32 months.













